Biologic Drugs

Mar 08, 2018
By Pharmaceutical Technology Editors
Under this agreement, the companies will develop in parallel an antibody drug candidate and cell lines for other potential candidates.
Mar 08, 2018
By Pharmaceutical Technology Editors
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Mar 06, 2018
By Pharmaceutical Technology Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 20, 2018
By Pharmaceutical Technology Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 13, 2018
By Pharmaceutical Technology Editors
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.
Feb 07, 2018
By Pharmaceutical Technology Editors
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
Feb 02, 2018
Pharmaceutical Technology
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
Feb 01, 2018
Pharmaceutical Technology
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Jan 31, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.
Jan 26, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Comecar will provide cell culture equipment for biopharmaceutical company CO.DON AG's new production site in Leipzig, Germany.
native1_300x100
lorem ipsum